SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment

NCT06010953 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Male
Hemophilia A With Inhibitor
Hemophilia B With Inhibitor
Hemophilia

Interventions

DRUG: SS109

Sponsor

Jiangsu Gensciences lnc.